Psivant Therapeutics
Emilio Gallicchio is currently an Associate Professor at Brooklyn College and a member of the doctoral faculty at The Graduate Center, City University of New York. Emilio also serves as a Scholar in Residence at Psivant Therapeutics, an Academic Editor at PLOS, and was previously a Scholar in Residence at Roivant Sciences. Emilio has an extensive background in scientific consulting, research, and high-performance computing, with a Ph.D. in Chemical Physics from Columbia University.
This person is not in any offices
Psivant Therapeutics
Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.